Microcap Ledger Lunai Bioworks Inc. $LNAI
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Pharmaceutical Preparations
- Headquarters
- Suite 906 Los Angeles, CA
- Fiscal year end
- June 30
- Shares outstanding
- 36,271,119 [10-Q 2026-05-15]
What the company doesAI summary of filing
Lunai Bioworks Inc. is a pre-clinical-stage biotechnology company with no products that have achieved regulatory approval. The company develops AI-based technology, gene therapy, cell therapy, and immunotherapy product candidates. It relies on substantial additional financing to support research, development, licensing, manufacture, and marketing of its product candidates, and depends on third parties such as universities and clinical research centers to perform research and development obligations. [10-K 2025-09-29]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 9 months to Mar 2026 | $20.9K | −$1.55M | −$3.45M | $3.16M | [10-Q 2026-05-15] |
| FY ended Jun 2025 | — | −$178.01M | −$7.87M | $92.7K | [10-K 2025-09-29] |
| FY ended Jun 2024 | — | −$88.43M | −$10.97M | $220.5K | [10-K 2025-09-29] |
- Quarterly cash burn
- −$1.15M
- Cash runway Estimate
- ~8.2 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-10-03 | 156,193,912 | [10-K/A 2025-02-19] |
| 2024-11-11 | 158,717,342 | [10-Q/A 2025-02-19] |
| 2025-02-12 | 158,717,509 | [10-Q 2025-02-19] |
| 2025-05-13 | 172,118,569 | [10-Q 2025-05-15] |
| 2025-09-26 | 231,802,470 | [10-K 2025-09-29] |
| 2025-11-10 | 23,432,391 | [10-Q 2025-11-14] |
| 2026-02-11 | 24,187,356 | [10-Q 2026-02-17] |
| 2026-05-15 | 36,271,119 | [10-Q 2026-05-15] |
- Shelf registration
- S-3 filed 2024-10-30; declared effective 2024-11-06 [S-3 2024-10-30]
Listing status
Current status: 10 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-05-01. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-05-01 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-05-01] |
| 2026-02-23 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-02-23] |
| 2026-02-12 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-02-12] |
| 2025-11-06 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-11-06] |
| 2025-10-30 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-10-30] |
| 2025-10-16 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-10-16] |
| 2025-08-06 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-08-06] |
| 2025-07-14 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-07-14] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-09 | 8-K | Other events |
| 2026-09-29 | NT 10-K | Notice of late annual report |
| 2026-07-17 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-06-17 | 8-K | Other events |
| 2026-06-16 | 8-K | Other events |
| 2026-05-20 | 8-K | Other events |
| 2026-05-15 | 10-Q | Quarterly report |
| 2026-05-13 | 8-K | Shareholder vote results |
| 2026-05-11 | 8-K | Listing notice or transfer |
| 2026-05-01 | 8-K | Material agreement entered; Acquisition or disposition completed; Listing notice or transfer |
| 2026-04-28 | 8-K | Other events |
| 2026-04-13 | DEF 14A | Proxy statement |
Alerts for $LNAI
Email me when Lunai Bioworks Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.